Compliance with new york state winter covid-19 plan drives demand for applied dna's pooled surveillance testing program

Stony brook, n.y.--(business wire)---- $apdn #covid19--applied dna sciences, inc. (nasdaq: apdn) (“applied dna” or the "company"), a leader in polymerase chain reaction (pcr)-based dna manufacturing, announced that its applied dna clinical laboratories, llc (adcl) subsidiary is experiencing growing demand for its safecircle™ pooled covid-19 surveillance testing program that is being primarily driven by new york state (the “state”) schools moving to comply with the state's winter covid-19 plan (the “plan”) that al
APDN Ratings Summary
APDN Quant Ranking